Figure 1.
Figure 1. SJCRH protocol total XIIIB: cumulative incidence of relapse. Cumulative incidence of relapse is not higher among TPMT heterozygotes than wild-type patients, adjusting dose of 6MP down among heterozygotes with prospective TPMT assessment.

SJCRH protocol total XIIIB: cumulative incidence of relapse. Cumulative incidence of relapse is not higher among TPMT heterozygotes than wild-type patients, adjusting dose of 6MP down among heterozygotes with prospective TPMT assessment.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal